Cleeland CS. Cancer-related symptoms. Semin Radiat Oncol 2000; 10: 17590.
Ripamonti C, Bruera E. Gastrointestinal symptoms in advanced cancer patients. Oxford; Oxford University Press; 2002.
Yamada R, Morita T, Yashiro E, Otani H, Amano K, Tei Y, et al. Patient-reported usefulness of peripherally inserted central venous catheters in terminally ill cancer patients. J Pain Symptom Manage 2010; 40: 60-6.
Park K, Lim HG, Hong JY, Song H. Safety and efficacy of peripherally inserted central catheters in terminally ill cancer patients: single institute experience. Korean J Hosp Palliat Care 2014; 17: 179-84.
Freytes CO. Vascular access problems revisited: the Multinational Association of Supportive Care in Cancer (MASCC) experience. Support Care Cancer 1998; 6: 13-9.
Pector JC. Vascular access problems. Support Care Cancer 1998; 6: 20-2.
Rosenthal VD, Bijie H, Maki DG, Mehta Y, Apisarnthanarak A, Medeiros EA, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. Am J Infect Control 2012; 40: 396-407.
Jeon MH, Park WB, Kim SR, Chun HK, Han SH, Bang JH, et al. Korean nosocomial infections surveillance system, intensive care unit module report:data summary from July 2010 through June 2011. Korean J Nosocomial Infect Control 2012; 17: 28-39.
O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011; 52: e162-93.
Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355: 2725-32.
Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 2009; 301: 1231-41.
Hentrich M, Schalk E, Schmidt-Hieber M, Chaberny I, Mousset S, Buchheidt D, et al. Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology. Ann Oncol 2014; 25: 936-47.
Park KH. Diagnosis and management of central venous catheter-related infections. Korean J Med 2014; 86: 282-94.
Guerin K, Wagner J, Rains K, Bessesen M. Reduction in central line-associated bloodstream infections by implementation of a postinsertion care bundle. Am J Infect Control 2010; 38: 430-3.
Park JY, Park YH. Factors associated with central venous catheterization in cancer patients. J Korean Oncol Nurs 2011; 11: 1-8.
Mercadante S, Ferrera P, Girelli D, Casuccio A. Patients' and relatives' perceptions about intravenous and subcutaneous hydration. J Pain Symptom Manage 2005 ;30: 354-8.
Yoo S, Jung SI, Kim GS, Lim DS, Sohn JW, Kim JY, et al. Interventions to prevent catheter-associated blood-stream infections: a multicenter study in Korea. Infect Chemother 2010; 42: 216-22.
Horattas MC, Trupiano J, Hopkins S, Pasini D, Martino C, Murty A. Changing concepts in long-term central venous access: catheter selection and cost savings. Am J Infect Control 2001; 29: 32-40.
Rosenthal VD, Maki DG, Rodrigues C, Alvarez-Moreno C, Leblebicioglu H, Sobreyra-Oropeza M, et al. Impact of International Nosocomial Infection Control Consortium (INICC) strategy on central line-associated bloodstream infection rates in the intensive care units of 15 developing countries. Infect Control Hosp Epidemiol 2010; 31: 1264-72.
Lin DM, Weeks K, Bauer L, Combes JR, George CT, Goeschel CA, et al. Eradicating central line-associated bloodstream infections statewide: the Hawaii experience. Am J Med Qual 2012; 27: 124-9.
Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a metaanalysis. Ann Intern Med 2002; 136: 792-801.